ASLM2023 Set to Take Place as In-Person Event in December at South Africa
|
By LabMedica International staff writers Posted on 20 Jul 2023 |

The African Society for Laboratory Medicine (ASLM, Addis Ababa, Ethiopia), a leading pan-African organization committed to advancing laboratory medicine and healthcare, has announced that its much-anticipated ASLM2023 conference will be held from 12 – 15 December 2023 at the Cape Town International Convention Centre (CTICC) in South Africa. This groundbreaking in-person event signifies a crucial turning point as ASLM's first face-to-face conference post-COVID-19, bringing together over 1200 professionals, experts, and researchers to examine the transformative potential of laboratory medicine and reshape Africa's healthcare future.
ASLM consistently champions the crucial role of laboratory medicine in African healthcare. Collaborating with key global, regional, and country stakeholders, the organization strengthens laboratory and diagnostic services and networks, ensuring global laboratory and diagnostic agendas mirror the country’s needs and priorities. ASLM implements targeted, multi-disciplinary, multi-stakeholder interventions based on evidence, globally accepted best practices, and standards. Moreover, ASLM serves as an important advocate for laboratory professionals in Africa, facilitating technical assistance provision by African experts.
Under the theme "Shaping Laboratory Systems and Diagnostic Services for the 21st Century: Embracing Change," the ASLM2023 conference will delve into innovative strategies to redefine laboratory medicine and healthcare in Africa. The conference will kick off with an opening ceremony on 12 December, followed by a three-day scientific program. Day 1 will examine the challenges and opportunities being faced by laboratory medicine in the 21st century. Day 2 will investigate emerging solutions designed to adapt to the dynamic field of laboratory medicine. Day 3 will concentrate on the path towards transforming laboratory medicine for this century. The conference will assemble experts from Africa and beyond to share their knowledge and experience. Activities will include plenary lectures, symposia, round tables, abstract-driven oral and poster sessions, exhibitions, and workshops.
ASLM2023 will have an impressive line-up of speakers, including Ambassador Dr. John Nkengasong, former Director of Africa CDC and the current US Global AIDS Coordinator for PEPFAR who will be presenting the ASLM2023 keynote speech and sharing invaluable insights from his more than 30 years of experience as public health leader. Among those leading the conference as co-chairs are Dr. Kamy Chetty, Chief Executive Officer of the National Health Laboratory Service, South Africa, and Professor Abderrahmane Maaroufi, Director of the Institut Pasteur, Morocco. The scientific co-chairs are Dr. Pascale Ondoa, Director of Science and New Initiatives at ASLM, and Professor Iruka Okeke, Professor at the University of Ibadan, Nigeria.
“As a pan-African professional society, ASLM effectively coordinates and mobilizes various actors to enhance local access to world-class diagnostic services, ensuring the health of African communities,” said Mr. Nqobile Ndlovu, CEO of ASLM, emphasizing the organization’s commitment. “Through this conference, we aim to bring together professionals, experts, and researchers in laboratory medicine to discuss advancements, share knowledge, and collaborate on addressing healthcare challenges in Africa.”
“We are excited to host the ASLM2023 conference in South Africa, and welcome all participants to Cape Town,” said Dr. Chetty. “This event offers a valuable platform for laboratory medicine professionals to come together, share insights, and shape the future of diagnostic services in Africa.”
“Nowhere else can you find an event of this caliber, which aspires to define the foundations of a new model for Africa’s medical laboratory systems for this century,” said Prof Maaroufi. “It’s an honor to co-chair ASLM2023 with Dr. Chetty and get the opportunity to share information and ideas with our colleagues from around the world.”
Related Links:
ASLM
Latest Industry News
- AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
- New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
- Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
- WHX Labs Dubai to Gather Global Experts in Antimicrobial Resistance at Inaugural AMR Leaders’ Summit
- BD and Penn Institute Collaborate to Advance Immunotherapy through Flow Cytometry
- Abbott Acquires Cancer-Screening Company Exact Sciences
- Roche and Freenome Collaborate to Develop Cancer Screening Tests
- Co-Diagnostics Forms New Business Unit to Develop AI-Powered Diagnostics
- Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
- Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
- Advanced Instruments Merged Under Nova Biomedical Name
- Bio-Rad and Biodesix Partner to Develop Droplet Digital PCR High Complexity Assays
- Hologic to be Acquired by Blackstone and TPG
- Bio-Techne and Oxford Nanopore to Accelerate Development of Genetics Portfolio
- Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders
- Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more







